Clinical Trials Sponsored by Providence Health & Services

Total 2438 results

Providence Health & Services

Recruiting

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

Primary Central Nervous System Lymphoma

United States
Providence Health & Services

Completed

Melatonin in Patients With Multiple Sclerosis (MS).

Relapsing Remitting Multiple Sclerosis

United States
Providence Health & Services

Active, not recruiting

Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

Malignant Epithelial Neoplasms

United States
Providence Health & Services

Available

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

KRAS G12V Mutant Advanced Epithelial Cancers
Providence Health & Services

Terminated

Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication

Multiple Sclerosis

United States
Providence Health & Services

Terminated

Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts

Depression | Fatigue | Sleep Deprivation

United States
Providence Health & Services

Unknown

Post-Mastectomy Surveillance to Detect Recurrence in Breast Cancer Patients

Breast Cancer

United States
Providence Health & Services

Completed

Vaginal Delivery Debrief Checklist to Improve Team Communication (VDD)

Other Specified Complications of Labor and Delivery

United States
Providence Health & Services

Terminated

Multi-Drug Desensitization Protocol for Heart Transplant Candidates

Heart Transplantation

United States
Providence Health & Services

Terminated

The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer

Mucositis

United States
Providence Health & Services

Completed

Carotid Artery Stenting With Protection Registry

Carotid Artery Stenosis

United States
Providence Health & Services

Unknown

Retrospective Study of the Impact of Drug Eluting Stents

Coronary Artery Disease

United States
Providence Health & Services

Recruiting

Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer

BRAF V600E Mutation Present | Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8 | Refractory Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | BRAF NP_004324.2:p.V600M | Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8 | Stage IVB Differentiated Thyroid Gland Carcinoma...

United States
Providence Health & Services

Active, not recruiting

Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Cancer of the Head and Neck

United States
Providence Health & Services

Completed

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Advanced Cancer

United States
Providence Health & Services

Withdrawn

Comparison Study of Insulin Glargine and NPH Insulin

Diabetes

United States
Providence Health & Services

Terminated

The Effects of Whole Food Intervention on Mucositis in Patients Treated for Thoracic Cancer

Esophagitis

United States
Providence Health & Services

Terminated

Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients (MTM)

Heart Failure

United States
Providence Health & Services

Withdrawn

Study of Immune Responses in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
Providence Health & Services

Active, not recruiting

Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer

Breast Cancer

United States
Providence Health & Services

Completed

Prevalence, Awareness and Management of Hypertension in Acute Care Personnel

Hypertension

United States
Providence Health & Services

Completed

Achieving the Quadruple Aim by Reducing Burnout

Burnout, Professional
Providence Health & Services

Terminated

Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)

Melanoma

United States
Providence Health & Services

Completed

α-TEA in Advanced Cancer

Metastatic Sarcoma | Metastatic Carcinoma | Metastatic Lymphoma

United States
Providence Health & Services

Completed

A Trial of Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy

Cholecystectomy, Laparoscopic

United States
Viralytics
Providence Health & Services

Completed

Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI) (MITCI)

Melanoma

United States
Providence Health & Services
Mallinckrodt

Completed

ACTH for Fatigue in Multiple Sclerosis Patients (ACTH)

Multiple Sclerosis, Relapsing-Remitting

United States
Providence Health & Services
AstraZeneca

Completed

Angiotensin II Antagonism of TGF-Beta 1

Hypertension | Diabetic Nephropathy

United States
Christiana Care Health Services
Providence Health & Services

Completed

Evaluating Decisional Regret Among Mothers

Pregnancy Preterm | Birth, Preterm | Extreme Prematurity

United States
Providence Health & Services
Inhibrx, Inc.

Not yet recruiting

Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients

Triple Negative Breast Cancer

United States
Providence Health & Services
MedImmune LLC

Completed

Anti-OX40 Antibody in Head and Neck Cancer Patients

Head and Neck Cancer

United States
Providence Health & Services
Microstein, LLC

Completed

Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

Multiple Sclerosis, Relapsing-Remitting

United States
Providence Health & Services
Seagen Inc.

Withdrawn

Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. (2019-101826)

Breast Cancer Stage IV

United States
Providence Health & Services
Celldex Therapeutics

Enrolling by invitation

Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

Malignant Epithelial Neoplasms

United States
Providence Health & Services
Verizon Wireless

Completed

Telemedicine Technology Demonstration Project for Heart Failure

Heart Failure

United States
Providence Health & Services
Taiho Oncology

Completed

SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer (SHORT)

Rectal Cancer

United States
Providence Health & Services
MedImmune LLC

Terminated

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Colorectal Neoplasms

United States
Providence Health & Services
MedImmune LLC

Completed

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate

United States
Providence Health & Services
Genentech, Inc.

Completed

Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab (PRECEPT)

Multiple Sclerosis | Infusion Reaction

United States
Providence Health & Services
Prometheus Laboratories

Active, not recruiting

Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma. (SBRT/IL-2)

Metastatic Melanoma

United States
Providence Health & Services
Cooler Heads

Active, not recruiting

Clinical Outcomes and Patient Satisfaction With Use of the Amma System

Breast Cancer

United States
Providence Health & Services
Genentech, Inc.

Completed

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab (OCTAVE)

Relapsing Remitting Multiple Sclerosis

United States
Providence Health & Services
OncoSec Medical Incorporated

Completed

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12)

SARS-CoV-2

United States
Providence Health & Services
BioFire Diagnostics, LLC

Completed

Pathogen Detection and Community Acquired Pneumonia

Community Acquired Pneumonia

United States
Providence Health & Services
Aduro Biotech, Inc.

Completed

Phase I Study of Safety and Immunogenicity of ADU-623

Brain Tumor | Glioblastoma Multiforme | Anaplastic Astrocytoma | Astrocytic Tumors

United States
Providence Health & Services
Bristol-Myers Squibb

Active, not recruiting

Ipilimumab for Head and Neck Cancer Patients

Squamous Cell Carcinoma of the Head and Neck

United States
Timothy Icenogle, MD

Withdrawn

The Destination Therapy Evaluation for Failing Fontan Study (DEFINe)

Single-ventricle | Failing Fontan Physiology | Failing Fontan | Single-ventricle Fontan | Single-ventricle Physiology

United States
Providence Health & Services
Brooklyn ImmunoTherapeutics, LLC

Active, not recruiting

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Breast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, Male

United States
Providence Health & Services
Galectin Therapeutics Inc.

Completed

GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients

Melanoma | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck

United States
Queen's University
Pfizer; Providence Health & Services; MDS Pharma Services

Completed

An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

Depression, Bipolar

Canada

Clinical Trials Sponsored by Providence Health & Services

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations